Pharmacodynamic assessment of histone deacetylase inhibitors: Infrared vibrational spectroscopic imaging of protein acetylation

被引:21
作者
Chen, Tsoching [1 ]
Lee, Min-Jung [2 ]
Kim, Yeong Sang [2 ]
Lee, Sunmin [2 ]
Kummar, Shivaani [3 ]
Gutierrez, Martin [3 ]
Hewitt, Stephen M. [3 ]
Trepel, Jane B. [2 ]
Levin, Ira W. [1 ]
机构
[1] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA
[2] NCI, Med Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[3] NCI, Tissue Array Res Program, Pathol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1021/ac800840y
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Infrared spectroscopy identifies molecules by detection of vibrational patterns characteristic of molecular bonds. We apply this approach to measure protein acetylation after treatment with histone deacetylase inhibitors. The anticancer activity of histone deacetylase inhibitors (HDACi) is ascribed to the hyperacetylation of both core nucleosomal histones and nonhistone proteins critical to the maintenance of the malignant phenotype (Marks, P. A.; Richon, V. M.; Breslow, R.; Rifkind, R. A. Curr. Opin. Oncol. 2001, 13, 477-483; Mai, A.; Massa, S.; Rotili, D.; Cerbara, I.; Valente, S.; Pezzi, R.; Simeoni, S.; Ragno, R. Med. Res. Rev. 2005, 25, 261-309). After incubation of the peripheral blood mononuclear cells (PBMCs) in vitro with the HDACi SNDX-275, a benzamide drug derivative, vibrational spectral changes in the methyl and methylene stretching mode regions, which reflect concentration-dependent increases in protein acetylation, were detected and quantified. We applied these metrics, based upon spectral differences, to peripheral blood mononuclear cells from patients treated in vivo with this agent. The data demonstrate a new approach to a sensitive assessment of global molecular modifications that is independent of antibodies, requires minimal cell processing, and is easily adapted to high-throughput screening.
引用
收藏
页码:6390 / 6396
页数:7
相关论文
共 28 条
[1]  
Blagosklonny MV, 2002, MOL CANCER THER, V1, P937
[2]   Application of vibrational spectroscopy to the study of mineralized tissues (review) [J].
Carden, A ;
Morris, MD .
JOURNAL OF BIOMEDICAL OPTICS, 2000, 5 (03) :259-268
[3]  
Chung EJ, 2005, ANN CLIN LAB SCI, V35, P397
[4]   Targeting epigenetic abnormalities with histone deacetylase inhibitors [J].
Conley, Barbara A. ;
Wright, John J. ;
Kummar, Shivaani .
CANCER, 2006, 107 (04) :832-840
[5]  
Diem M, 2000, BIOPOLYMERS, V57, P282, DOI 10.1002/1097-0282(2000)57:5<282::AID-BIP50>3.0.CO
[6]  
2-R
[7]   IR spectra and IR spectral maps of individual normal and cancerous cells [J].
Diem, M ;
Chiriboga, L ;
Lasch, P ;
Pacifico, A .
BIOPOLYMERS, 2002, 67 (4-5) :349-353
[8]   Infrared spectroscopic imaging for histopathologic recognition [J].
Fernandez, DC ;
Bhargava, R ;
Hewitt, SM ;
Levin, IW .
NATURE BIOTECHNOLOGY, 2005, 23 (04) :469-474
[9]   Acetylation of nuclear receptors in cellular growth and apoptosis [J].
Fu, MF ;
Wang, CG ;
Zhang, XP ;
Pestell, RG .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (06) :1199-1208
[10]   In vivo margin assessment during partial mastectomy breast surgery using Raman spectroscopy [J].
Haka, AS ;
Volynskaya, Z ;
Gardecki, JA ;
Nazemi, J ;
Lyons, J ;
Hicks, D ;
Fitzmaurice, M ;
Dasari, RR ;
Crowe, JP ;
Feld, MS .
CANCER RESEARCH, 2006, 66 (06) :3317-3322